Embryo culture from zygote to blastocyst & the Gardner grading system
Fertilization produces a zygote — a single totipotent cell containing two visible pronuclei (2PN), one from each parent. Over the next 48–72 hours, the zygote divides repeatedly without net growth, partitioning its cytoplasm into progressively smaller blastomeres while the surrounding zona pellucida keeps every cell contained as one embryo.
Roughly 16–20 hours after sperm entry (or ICSI injection), the fertilized oocyte reaches the 2PN stage — two distinct pronuclei, one maternal and one paternal, are visible side-by-side in the cytoplasm, each surrounded by its own nuclear envelope and containing decondensed chromatin with visible nucleolar precursor bodies (NPBs).
The number, size, and alignment of NPBs within each pronucleus, along with pronuclear apposition at the cytoplasmic center, are graded (Z-scoring systems, e.g. Scott/Z1–Z4) as early predictors of developmental competence — before any cell division has even occurred.
Syngamy — the breakdown of both pronuclear envelopes and merging of maternal and paternal chromosomes on a single mitotic spindle — occurs shortly before the first cleavage division, formally creating the diploid zygote genome.
The zygote undergoes a series of rapid mitotic divisions called cleavage. Unlike typical mitosis, these divisions are not accompanied by cell growth — the total embryo volume stays roughly constant while it is repeatedly subdivided into smaller blastomeres, all held together within the zona pellucida.
Typical timeline: 2-cell by ~Day 2 morning, 4-cell by ~Day 2 evening / Day 3 morning, 8-cell by Day 3. Early divisions (through the 4- to 8-cell stage) are driven almost entirely by maternal mRNA and protein stockpiled in the oocyte before fertilization — the embryo's own genome is largely silent.
Embryonic genome activation (EGA) — the major, minor activation of transcription from the embryo's own genome — occurs at the 4- to 8-cell stage (~Day 3) in humans, considerably later than in mice (2-cell stage). This is a critical developmental checkpoint: embryos with genomic or maternal-transcript defects frequently arrest around this time ("Day-3 block").
Roughly 50–60% of embryos that reach the 8-cell stage carry at least some degree of chromosomal mosaicism due to post-zygotic mitotic errors — a major reason why morphology alone cannot fully predict chromosomal normalcy (euploidy).
Time-lapse incubators capture images every 5–20 minutes without removing embryos from stable culture conditions, allowing precise, non-invasive measurement of division timing ("morphokinetics"). Key annotated parameters include:
• t2 — time to first cleavage (2-cell), typically ~25–27 h post-insemination/ICSI • t3, t4, t5 — time to 3-, 4-, and 5-cell stages • cc2 (t3−t2) — duration of the second cell cycle; abnormally short or long cc2 correlates with lower blastulation and implantation rates • s2 (t4−t3) — synchrony of the second division; highly asynchronous divisions suggest chromosomal errors • tSB — time to start of blastulation (~Day 4, ~96–100 h) • tB — time to full blastocyst (~Day 5–6, ~110–120 h)
Algorithms (e.g. KIDScore) combine these kinetic parameters with static morphology to rank embryos objectively, reducing inter-observer variability in manual grading.
Around Day 4, loosely apposed blastomeres undergo a dramatic morphological transition: they flatten against one another, maximize their contact surface area, and lose their individually visible cell borders. The resulting compact, mulberry-shaped structure — the morula (Latin for "mulberry") — is the embryo's first step toward becoming a functionally polarized tissue.
Compaction is driven by the redistribution of E-cadherin (a calcium-dependent adhesion protein) from a diffuse pattern across the whole blastomere surface to a concentrated ring at cell–cell contact points. Actin-myosin contractility pulls neighboring membranes into tight apposition, flattening each cell against its neighbors and eliminating the visible intercellular spaces that were obvious at the 8-cell stage.
This is also the embryo's first act of cell polarization: each blastomere develops a distinct outer (apical) surface facing the zona pellucida and an inner (basolateral) surface facing neighboring cells — the first molecular asymmetry that will later determine which cells become trophectoderm and which become inner cell mass.
Compaction and the following days of culture place changing metabolic demands on the embryo, and IVF laboratories use one of two media philosophies to meet them:
• Sequential (stepwise) media: a "cleavage medium" (Days 1–3, e.g. G1) low in glucose but rich in pyruvate/lactate mirrors the fallopian tube environment; a "blastocyst medium" (Days 3–6, e.g. G2) with higher glucose and amino acid content mirrors the uterine environment as the embryo's own glycolytic machinery matures. Requires a media change around Day 3.
• Single-step (continuous) media: one formulation, balanced to support the embryo from zygote through blastocyst without a medium change, reducing handling and micro-environment disruption (undisturbed / "back-to-base" culture) — often paired with time-lapse incubators.
Both approaches, when combined with physiologic (5–6%) CO₂/low (5%) O₂ tri-gas incubation, achieve comparable blastocyst and pregnancy rates in most clinical settings; the choice is largely a matter of laboratory workflow.
Before Day 4, embryologists grade cleavage-stage embryos on three morphological criteria, still commonly used to select which embryos to culture further or, in some clinics, transfer on Day 3:
• Cell number relative to age (4-cell Day 2, 8-cell Day 3 = "on time") • Blastomere symmetry — equal-sized cells score higher than grossly unequal cells • Fragmentation — anucleate cytoplasmic fragments pinched off during division; graded as <10% (minimal), 10–25% (mild), 25–35% (moderate), or >35% (severe)
Multinucleation (more than one nucleus per blastomere, visible on Day 2) is an additional red flag, associated with chromosomal mosaicism and lower implantation potential even when cell number and fragmentation look favorable.
Embryos with >25% fragmentation on Day 3 are roughly half as likely to reach a usable blastocyst compared with embryos showing minimal fragmentation — fragmentation load is one of the strongest single morphological predictors of blastulation failure.
The morula's outer cells seal themselves into a continuous epithelium and begin actively pumping fluid inward. A fluid-filled cavity — the blastocoel — appears and steadily expands, transforming the solid mulberry-shaped morula into a fluid-filled sphere: the blastocyst. This is the developmental milestone that defines a transferable, or freezable, embryo.
Outer morula cells (the future trophectoderm) first seal the embryo by forming tight junctions between neighboring cells, creating a continuous, fluid-impermeable epithelium — much like the outer layer of skin. Simultaneously, Na⁺/K⁺-ATPase pumps are asymmetrically inserted into the basolateral (inward-facing) membrane of these cells.
These pumps actively transport sodium ions into the intercellular space between the outer epithelium and the inner cell cluster. Water follows osmotically through aquaporin channels, and small fluid pockets coalesce into a single, expanding cavity — the blastocoel. The embryo has, in effect, built its own miniature secretory epithelium days before any organ exists.
The size of the blastocoel relative to total embryo volume, and whether the embryo has begun hatching from the zona, defines the first digit of the Gardner grade:
1 — Early blastocyst: blastocoel less than half the embryo volume 2 — Blastocoel at least half the embryo volume 3 — Full blastocyst: blastocoel completely fills the embryo 4 — Expanded blastocyst: blastocoel volume larger than the original embryo; zona thinning 5 — Hatching blastocyst: trophectoderm herniating through a breach in the zona 6 — Fully hatched blastocyst: embryo completely escaped from the zona pellucida
As the cavity expands, the zona pellucida is mechanically stretched and enzymatically thinned (by trophectoderm-secreted proteases), dropping from ~15 µm at the morula stage to under 5 µm by full expansion — a mechanical prerequisite for hatching and, ultimately, implantation.
Expansion grade correlates strongly with implantation: expanded (grade 4+) blastocysts on Day 5 implant substantially more often than same-grade blastocysts that only reach full expansion on Day 6, because faster-developing embryos are, on average, more likely to be chromosomally normal (euploid).
Not every fertilized oocyte reaches this stage. Across the cleavage-to-blastocyst transition, a substantial fraction of embryos arrest — most commonly around compaction or early cavitation — due to chromosomal abnormalities, mitochondrial insufficiency, or maternal-to-embryonic transcript failure.
On average, roughly 40–50% of 2PN fertilized oocytes develop into a usable blastocyst by Day 5–6 in standard IVF culture, though this proportion varies considerably with maternal age, oocyte quality, and laboratory conditions — dropping well below 30% in women over 40, and exceeding 60% in favorable young-donor cycles.
This attrition is not simply a laboratory artifact: extended culture to the blastocyst stage functions as a natural selection filter, allowing embryologists to identify embryos with the best combination of developmental competence before choosing which to transfer or cryopreserve.
As the blastocoel expands, the once-uniform morula resolves into two molecularly and functionally distinct cell lineages: a compact inner cell mass (ICM) pressed against one pole of the cavity, and a thin trophectoderm (TE) epithelium lining the rest of the sphere. This is the embryo's first lineage decision — and it separates the cells that will become the baby from the cells that will become the placenta.
Cell fate at this stage is governed by position and the Hippo signaling pathway. Outer cells, exposed to the zona pellucida on one face and neighboring cells on the other (apical-basal polarity established during compaction), experience low Hippo pathway activity — allowing the transcriptional co-activator YAP to enter the nucleus and, together with TEAD4, switch on trophectoderm genes (CDX2, GATA3).
Inner cells, completely surrounded by neighbors and lacking any free apical surface, experience high Hippo pathway activity, which phosphorylates and cytoplasmically sequesters YAP — silencing CDX2 and instead permitting the pluripotency network (OCT4/POU5F1, SOX2, NANOG) to remain active, specifying inner cell mass fate.
A second lineage decision follows within the ICM itself around Day 6–7: epiblast (NANOG⁺, forms the fetus proper) segregates from primitive endoderm (GATA6⁺, forms the yolk sac), in a "salt-and-pepper" pattern that resolves via FGF/ERK signaling.
The ICM is a tightly packed cluster of pluripotent cells, typically visible as a distinct, dense clump adherent to the inner trophectoderm wall at one pole of the blastocyst ("polar" morphology). Its cells retain the capacity to give rise to every cell type of the fetus — all three germ layers (ectoderm, mesoderm, endoderm) and the germline.
Human embryonic stem cell (hESC) lines are derived by isolating and culturing ICM cells from donated blastocysts, exploiting exactly this pluripotency. In vivo, the ICM (specifically its epiblast component) is what implants and develops into the embryo proper — everything a person will become originates from these roughly 20–30 cells.
The trophectoderm is the embryo's first differentiated epithelial tissue: a single continuous cell layer joined by tight and gap junctions, responsible for building and maintaining the blastocoel, and ultimately for implantation. On contact with the uterine epithelium, trophectoderm cells at the implantation pole will fuse into multinucleated syncytiotrophoblast, invading the endometrium and later forming the placenta and chorionic villi.
Because the TE is what interfaces directly with maternal tissue, its cell number, packing, and epithelial integrity are strong predictors of successful implantation — arguably as important clinically as the ICM itself, since a poor TE can fail to implant even a genetically normal, high-quality ICM.
Trophectoderm cells — not the inner cell mass — are the safest source for preimplantation genetic testing for aneuploidy (PGT-A): a 5–10 cell TE biopsy on Day 5–6 provides a chromosomal snapshot with minimal disruption to the ICM that will become the baby.
Developed by David Gardner and colleagues in the late 1990s, the Gardner grading system distills blastocyst morphology into a compact three-part code — expansion grade, ICM grade, trophectoderm grade — such as "4AA". It remains the most widely used morphological framework worldwide for ranking blastocysts and deciding which to transfer, freeze, or discard.
A Gardner grade has three components, always read in the same order:
1. Expansion grade (1–6): how far the blastocoel has expanded and whether hatching has begun (see Stage 3) — a numeral.
2. ICM grade (A, B, or C), assessed only once expansion reaches grade 3 or above: A — many cells, tightly packed B — several cells, loosely grouped C — very few cells
3. TE grade (A, B, or C): A — many cells forming a cohesive, tightly-joined epithelium B — few cells forming a loose epithelium C — very few, large, sparse cells
So "4AA" denotes an expanded blastocyst (grade 4) with an excellent inner cell mass (A) and an excellent trophectoderm (A) — the archetypal top-quality embryo. A "3BC" is a just-full blastocyst (grade 3) with a fair ICM (B) and a poor TE (C).
Across large clinical series, all three grade components independently predict implantation, but they are not equally weighted — TE grade tends to be the strongest single morphological predictor, since it reflects the tissue that must physically invade the endometrium, closely followed by expansion grade and then ICM grade.
Approximate per-embryo implantation potential by combined grade (illustrative, pooled from published series): 5AA/6AA (hatching/hatched, top ICM+TE) ≈ 65–70%; 4AA ≈ 60–65%; 4AB or 4BA ≈ 50–55%; 3BB ≈ 40–45%; 3BC or 3CB ≈ 20–30%; 2CC or lower ≈ <15%.
Morphology remains an imperfect proxy for chromosomal normalcy — some morphologically excellent blastocysts are aneuploid, and some lower-grade blastocysts are euploid — which is why grading is often combined with, not replaced by, PGT-A chromosomal screening in clinics where it is available.
A high Gardner grade does not guarantee euploidy, but the correlation is real: euploidy rates rise from roughly 30–40% in poorly-graded blastocysts to 60–70% in top-graded (AA/AB) blastocysts in most published cohorts, which is why morphology still meaningfully improves embryo ranking even without genetic testing.
Grading exists to answer a practical question: which embryo(s), among those available, should be transferred first? Modern practice increasingly favors elective single embryo transfer (eSET) of the single best-graded (and, where available, euploid) blastocyst, to maximize the chance of a healthy singleton pregnancy while minimizing the risks of multiple gestation.
Lower-graded blastocysts are not necessarily discarded: many programs still cryopreserve (vitrify) grade 3BB or better blastocysts for future frozen embryo transfer (FET) cycles, since even moderate-grade embryos carry meaningful implantation potential and FET outcomes are now comparable to, or better than, fresh transfer in many protocols.
Ultimately, Gardner grading — refined by time-lapse morphokinetics and, where indicated, PGT-A — gives embryologists and clinicians a common, reproducible language for ranking embryos, prioritizing transfer order, and setting realistic expectations for each IVF cycle.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| 5AA / 6AA | Hatching / fully hatched, top ICM & TE | Cavity fully expanded, embryo escaping or free of the zona | ≈ 65–70% per embryo — highest transfer priority |
| 4AA | Expanded blastocyst, top ICM & TE | Cavity larger than original embryo volume, zona thinning | ≈ 60–65% per embryo — archetypal top-quality embryo |
| 4AB / 4BA | Expanded, one lineage excellent, one good | Slightly fewer / looser cells in ICM or TE | ≈ 50–55% per embryo — strong transfer candidate |
| 3BB | Full blastocyst, fair ICM & TE | Cavity fills embryo, moderate cell packing in both layers | ≈ 40–45% per embryo — good FET candidate |
| 3BC / 3CB | Full blastocyst, one lineage poor | Sparse cells in ICM or TE, incomplete epithelium | ≈ 20–30% per embryo — lower selection priority |
| 2CC or lower | Early/minimal cavity, poor ICM & TE | Few, sparse cells in both lineages, slow development | ≈ <15% per embryo — least prioritized for transfer |